BD Alaris System. The EtCO2 module is a capnograph indicated for continuous, noninvasive monitori...

FDA Device Recall #Z-2935-2020 — Class II — August 4, 2020

Recall Summary

Recall Number Z-2935-2020
Classification Class II — Moderate risk
Date Initiated August 4, 2020
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm CareFusion 303, Inc.
Location San Diego, CA
Product Type Devices
Quantity 680 units

Product Description

BD Alaris System. The EtCO2 module is a capnograph indicated for continuous, noninvasive monitoring of end tidal carbon dioxide (EtCO2), fractional inspired carbon dioxide (FiCO2) and respiratory rate (RR). The EtCO2 module and disposables are indicated for use with intubated and nonintubated adult, pediatric and neonatal patients. It is not intended for direct connection to ventilator or breathing systems. Only one EtCO2 module can be connected to the Alaris System.

Reason for Recall

Infusion pump component defect may result in interruption of patient monitoring

Distribution Pattern

U.S. Nationwide distribution including in the states of AZ, CA, FL, GA, IA, ID, IL, KS, LA, MI, MN, MO, MS, MT, NC, NE, NV, NY, OH, PA, SC, TX, WA, WI. OUS.: None

Lot / Code Information

Model: EtCO2 8300; Lot/Serial numbers: 10002682711, 10002720508, 1000287042, 10002882569

Other Recalls from CareFusion 303, Inc.

Recall # Classification Product Date
Z-1645-2026 Class II BD Alaris" System with Guardrails" Suite MX wit... Feb 11, 2026
Z-1028-2026 Class II BD Pyxis ES Enterprise Server Catalog Numbers 1... Dec 3, 2025
Z-0962-2026 Class II BD Pyxis MedStation ES, REF: 323, BD Pyxis M... Nov 20, 2025
Z-1217-2026 Class II BD Alaris" Pump Module model 8100 UDI-DI code:... Nov 6, 2025
Z-0430-2026 Class I BD Alaris infusion Pump Module 8100, REF: 8100;... Oct 17, 2025

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.